IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 35 filers reported holding IKENA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,239,808 | -26.9% | 517,216 | +10.7% | 0.00% | – |
| Q2 2023 | $3,064,825 | +266.0% | 467,199 | +92.5% | 0.00% | – |
| Q1 2023 | $837,384 | +133241.4% | 242,720 | +2.7% | 0.00% | – |
| Q4 2022 | $628 | -99.9% | 236,434 | -0.2% | 0.00% | – |
| Q3 2022 | $841,000 | +85.2% | 236,948 | +130.8% | 0.00% | – |
| Q2 2022 | $454,000 | -77.4% | 102,674 | -68.8% | 0.00% | – |
| Q1 2022 | $2,006,000 | -43.8% | 329,003 | +15.7% | 0.00% | – |
| Q4 2021 | $3,567,000 | +45.4% | 284,454 | +46.3% | 0.00% | – |
| Q3 2021 | $2,454,000 | +49.1% | 194,461 | +65.9% | 0.00% | – |
| Q2 2021 | $1,646,000 | – | 117,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,249,123 | $9,738,703 | 8.94% |
| CHI Advisors LLC | 2,180,934 | $9,443,445 | 3.74% |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $21,728,711 | 3.36% |
| ACUTA CAPITAL PARTNERS, LLC | 551,010 | $2,385,873 | 1.60% |
| Vida Ventures Advisors, LLC | 225,192 | $975,081 | 1.51% |
| BVF INC/IL | 3,169,164 | $13,722,480 | 0.37% |
| Artal Group S.A. | 1,849,513 | $8,008 | 0.34% |
| Orbimed Advisors | 3,186,166 | $13,796,099 | 0.29% |
| OUP Management Co., LLC | 26,833 | $116,187 | 0.26% |
| Avoro Capital Advisors LLC | 1,640,000 | $7,101,200 | 0.11% |